Program Seeks to Accelerate the Development of Cures and Therapies for Rare Diseases
The Harrington Rare Disease Scholar Award was created to advance breakthrough research into novel treatments for rare diseases. The Harrington Rare Disease Scholar Program is sponsored by Takeda Pharmaceutical Company Limited and overseen by Harrington Discovery Institute. To learn more about the collaboration, please go to About Our Partnership.
The Harrington Rare Disease Scholar Program will provide funding and hands-on drug development guidance for two years to U.S.-based PhD and MD researchers whose discoveries show promise for translation into novel medicines for rare diseases.
Harrington InnovationSupport Center